Assembly Biosciences Management
Management criteria checks 3/4
Assembly Biosciences' CEO is Jason Okazaki, appointed in Aug 2022, has a tenure of 1.75 years. total yearly compensation is $1.37M, comprised of 43.7% salary and 56.3% bonuses, including company stock and options. directly owns 0.19% of the company’s shares, worth €125.24K. The average tenure of the management team and the board of directors is 3.5 years and 4.3 years respectively.
Key information
Jason Okazaki
Chief executive officer
US$1.4m
Total compensation
| CEO salary percentage | 43.7% |
| CEO tenure | 1.8yrs |
| CEO ownership | 0.2% |
| Management average tenure | 3.5yrs |
| Board average tenure | 4.3yrs |
Recent management updates
Recent updates
CEO Compensation Analysis
| Date | Total Compensation | Salary | Company Earnings |
|---|---|---|---|
| Dec 31 2023 | US$1m | US$600k | -US$61m |
| Sep 30 2023 | n/a | n/a | -US$73m |
| Jun 30 2023 | n/a | n/a | -US$81m |
| Mar 31 2023 | n/a | n/a | -US$89m |
| Dec 31 2022 | US$2m | US$555k | -US$93m |
| Sep 30 2022 | n/a | n/a | -US$131m |
| Jun 30 2022 | n/a | n/a | -US$127m |
| Mar 31 2022 | n/a | n/a | -US$126m |
| Dec 31 2021 | US$1m | US$533k | -US$130m |
| Sep 30 2021 | n/a | n/a | -US$109m |
| Jun 30 2021 | n/a | n/a | -US$94m |
| Mar 31 2021 | n/a | n/a | -US$63m |
| Dec 31 2020 | US$4m | US$394k | -US$62m |
Compensation vs Market: Jason's total compensation ($USD1.37M) is above average for companies of similar size in the German market ($USD399.70K).
Compensation vs Earnings: Jason's compensation has been consistent with company performance over the past year.
CEO
Jason Okazaki (47 yo)
1.8yrs
Tenure
US$1,373,710
Compensation
Mr. Jason A. Okazaki serves as Chief Executive Officer and Director at Assembly Biosciences, Inc. since January 01, 2023. He served as Chief Operating Officer of Assembly Biosciences, Inc. since August 1,...
Leadership Team
| Name | Position | Tenure | Compensation | Ownership |
|---|---|---|---|---|
| CEO, President & Director | 1.8yrs | US$1.37m | 0.19% $ 125.2k | |
| Chief Scientific Officer | 3.3yrs | US$811.82k | 0.18% $ 121.4k | |
| Chief Manufacturing Officer | 3.5yrs | US$705.51k | 0.16% $ 109.0k | |
| Co-Founder and Clinical & Scientific Advisor | 9.8yrs | US$1.50m | no data | |
| Co-Founder | no data | no data | no data | |
| Executive Director of Accounting & Treasury | no data | no data | 0.028% $ 19.0k | |
| Senior Vice President of Investor Relations | no data | no data | no data | |
| Chief Human Resources Officer | 6.5yrs | no data | no data | |
| Chief Medical Officer | less than a year | no data | no data | |
| Executive Officer | 6.1yrs | US$652.02k | no data | |
| Investor Relations Consultant | no data | no data | no data |
3.5yrs
Average Tenure
51yo
Average Age
Experienced Management: V7B's management team is considered experienced (3.5 years average tenure).
Board Members
| Name | Position | Tenure | Compensation | Ownership |
|---|---|---|---|---|
| CEO, President & Director | 1.3yrs | US$1.37m | 0.19% $ 125.2k | |
| Co-Founder | 9.8yrs | no data | no data | |
| Independent Director | 12.3yrs | US$79.58k | 0.012% $ 8.2k | |
| Independent Non-Executive Chairman | 9.8yrs | US$122.08k | 0.027% $ 17.8k | |
| Director | 4.8yrs | US$64.58k | 0.22% $ 144.1k | |
| Independent Director | 6.4yrs | US$74.58k | 0% $ 0 | |
| Independent Director | 3.6yrs | US$72.08k | 0.084% $ 56.0k | |
| Member of Scientific Advisory Board | 4.3yrs | no data | no data | |
| Member of Scientific Advisory Board | 4.3yrs | no data | no data | |
| Member of Scientific Advisory Board | 4.3yrs | no data | no data | |
| Member of Scientific Advisory Board | 4.3yrs | no data | no data | |
| Member of Scientific Advisory Board | 4.3yrs | no data | no data |
4.3yrs
Average Tenure
62yo
Average Age
Experienced Board: V7B's board of directors are considered experienced (4.3 years average tenure).